Charlotte Bradbury

5.5k total citations
36 papers, 1.1k citations indexed

About

Charlotte Bradbury is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Charlotte Bradbury has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Charlotte Bradbury's work include Platelet Disorders and Treatments (12 papers), Blood groups and transfusion (8 papers) and Acute Myeloid Leukemia Research (6 papers). Charlotte Bradbury is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Blood groups and transfusion (8 papers) and Acute Myeloid Leukemia Research (6 papers). Charlotte Bradbury collaborates with scholars based in United Kingdom, United States and Canada. Charlotte Bradbury's co-authors include Bryan M. Turner, Mark T. Drayson, Charles Craddock, Farhat L. Khanim, Christopher M. Bunce, Devin White, Rachel Hayden, Karl P. Nightingale, Florian Hollfelder and Susanne Gendreizig and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Charlotte Bradbury

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte Bradbury United Kingdom 15 451 308 194 180 168 36 1.1k
Jean‐Marie Leclerc Canada 18 167 0.4× 139 0.5× 320 1.6× 39 0.2× 91 0.5× 57 1.1k
Danai Bem United Kingdom 15 88 0.2× 330 1.1× 32 0.2× 66 0.4× 17 0.1× 27 787
Neil A. Lachant United States 16 116 0.3× 334 1.1× 147 0.8× 38 0.2× 115 0.7× 51 990
Shamkant Mulgaonkar United States 22 367 0.8× 106 0.3× 292 1.5× 25 0.1× 82 0.5× 38 2.0k
Stella Bowcock United Kingdom 13 102 0.2× 254 0.8× 116 0.6× 11 0.1× 65 0.4× 43 727
Yu‐Min Shen United States 11 111 0.2× 202 0.7× 99 0.5× 39 0.2× 12 0.1× 39 554
Maher Issa United States 19 94 0.2× 182 0.6× 168 0.9× 19 0.1× 51 0.3× 26 965
Karon Abe United States 18 475 1.1× 144 0.5× 119 0.6× 123 0.7× 23 0.1× 46 1.2k
Samart Pakakasama Thailand 25 434 1.0× 472 1.5× 334 1.7× 17 0.1× 119 0.7× 130 1.6k
Suchitra Pandey United States 10 85 0.2× 174 0.6× 143 0.7× 28 0.2× 194 1.2× 28 1.2k

Countries citing papers authored by Charlotte Bradbury

Since Specialization
Citations

This map shows the geographic impact of Charlotte Bradbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Bradbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Bradbury more than expected).

Fields of papers citing papers by Charlotte Bradbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Bradbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Bradbury. The network helps show where Charlotte Bradbury may publish in the future.

Co-authorship network of co-authors of Charlotte Bradbury

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte Bradbury. A scholar is included among the top collaborators of Charlotte Bradbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte Bradbury. Charlotte Bradbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Julia, Bruno Charbit, Emily L. Williams, et al.. (2023). Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia. British Journal of Haematology. 204(2). 644–648. 3 indexed citations
2.
Lester, Will, Niki L. Walker, Kailash P. Bhatia, et al.. (2023). British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves. British Journal of Haematology. 202(3). 465–478. 9 indexed citations
3.
Schulman, Sam, Michelle Sholzberg, Alex C. Spyropoulos, et al.. (2022). ISTH guidelines for antithrombotic treatment in COVID‐19. Journal of Thrombosis and Haemostasis. 20(10). 2214–2225. 91 indexed citations
4.
Cooper, Nichola, Quentin A. Hill, John D. Grainger, et al.. (2021). Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel. Acta Haematologica. 144(4). 418–426. 19 indexed citations
5.
Bradbury, Charlotte, Quentin A. Hill, Catherine Bagot, et al.. (2021). Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia. New England Journal of Medicine. 385(10). 885–895. 55 indexed citations
6.
Shah, Akshay, Killian Donovan, Manish Pandey, et al.. (2020). Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study. Critical Care. 24(1). 561–561. 79 indexed citations
7.
8.
9.
10.
Swan, Dawn, Alberto Rocci, Charlotte Bradbury, & Jecko Thachil. (2018). Venous thromboembolism in multiple myeloma – choice of prophylaxis, role of direct oral anticoagulants and special considerations. British Journal of Haematology. 183(4). 538–556. 44 indexed citations
11.
Bradbury, Charlotte. (2017). Thrombotic Events in Patients with Myeloma Treated with Immunomodulatory Drugs; Results of the Myeloma XI Study. Blood. 130. 553–553. 15 indexed citations
12.
Khan, Naeem, Robert K. Hills, Steven Knapper, et al.. (2016). Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia. PLoS ONE. 11(9). e0163291–e0163291. 10 indexed citations
13.
Bradbury, Charlotte, et al.. (2014). Innovative postoperative bra for patients with drains following breast surgery. Annals of The Royal College of Surgeons of England. 96(3). 241–241.
14.
Vyas, Paresh, Charlotte Bradbury, Peter Richardson, et al.. (2013). COMBINED ANALYSES OF ROS, CELL CYCLE AND IMMUNOPHENOTYPE SHOWS THAT NORMAL HEMATOPOIETIC PROGENITOR SUBSETS HAVE A DIFFERENTIAL ROS PROFILE THAT IS LOST IN ACUTE MYELOID LEUKEMIA. Haematologica. 98. 12–12. 1 indexed citations
15.
Curran, Vernon, et al.. (2008). A qualitative study of the international medical graduate and the orientation process.. PubMed. 13(4). 163–9. 40 indexed citations
16.
Khanim, Farhat L., Charlotte Bradbury, Julie Arrazi, et al.. (2008). Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML. British Journal of Haematology. 144(3). 332–341. 17 indexed citations
17.
Nightingale, Karl P., et al.. (2006). Cross-talk between Histone Modifications in Response to Histone Deacetylase Inhibitors. Journal of Biological Chemistry. 282(7). 4408–4416. 160 indexed citations
18.
Craddock, Charles, Charlotte Bradbury, Sujaatha Narayanan, et al.. (2005). Predictors of Clinical Response in Patients with High Risk Acute Myeloid Leukemia Receiving Treatment with the Histone Deacetylase Inhibitor Sodium Valproate.. Blood. 106(11). 2791–2791. 7 indexed citations
19.
Bradbury, Charlotte, Farhat L. Khanim, Rachel Hayden, et al.. (2005). Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia. 19(10). 1751–1759. 332 indexed citations
20.
Kearney, Mairead, Charlotte Bradbury, Basma Ellahi, Michael J. Hodgson, & Miranda Thurston. (2005). Mainstreaming prevention: Prescribing fruit and vegetables as a brief intervention in primary care. Public Health. 119(11). 981–986. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Leclerc Breakdown of academic impact, for papers by Danai Bem Breakdown of academic impact, for papers by Neil A. Lachant Breakdown of academic impact, for papers by Shamkant Mulgaonkar Breakdown of academic impact, for papers by Stella Bowcock Breakdown of academic impact, for papers by Yu‐Min Shen Breakdown of academic impact, for papers by Maher Issa Breakdown of academic impact, for papers by Karon Abe Breakdown of academic impact, for papers by Samart Pakakasama Breakdown of academic impact, for papers by Suchitra Pandey
Rankless by CCL
2026